Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059735 · ClinicalTrials.gov registry record · Phase 2
A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma
A Phase 2 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00059735 is a Phase 2 study that has completed, run by Eisai. The registered enrollment target is 30 participants.
The verdict
NCT00059735, a Phase 2 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.
Interventions
- DRUG E7070
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2002-05 |
| Est. Completion | 2003-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059735
The ClinicalTrials.gov registry entry for NCT00059735 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E7070 is the first listed.
NCT00059735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00059735 about?
NCT00059735 is a clinical study titled "A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma". The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.
What is the current status of trial NCT00059735?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2002-05. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00059735?
The interventions under investigation include: E7070 (DRUG).
Who is sponsoring clinical trial NCT00059735?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.